Consolidated Statements of Assets and Liabilities - USD ($)		Mar. 31, 2025	Dec. 31, 2024
Investments at fair value:
Investments at fair value	[1]	$ 375,823,562	$ 377,640,318
Cash		4,578,449	4,028,665
Interest receivable		4,652,720	3,887,028
Receivable for investments sold		4,306,473	0
Deferred financing cost		2,016,186	2,169,211
Prepaid expenses		2,004	6,748
Paydown receivable		0	341,471
Total assets		391,379,394	388,073,441
LIABILITIES
Credit facility payable		122,300,000	122,500,000
Subscriptions received in advance		8,765,989	0
Redemptions payable		6,290,542	5,637,890
Deferred tax liabilities		6,144,344	6,094,196
Incentive fees payable (Note 6)		3,680,126	2,813,724
Credit facility interest payable		2,268,985	2,267,199
Other payables		1,621,292	900,145
Management fees payable (Note 6)		1,345,156	1,157,509
Professional fees payable		329,197	434,744
Reimbursement expense payable		177,329	77,275
Legal fees payable		74,897	37,883
Due to feeder fund		22,720	0
Distributions payable		0	5,322,771
Total liabilities		153,020,577	147,243,336
Commitments and contingencies (Note 11)
NET ASSETS
Common shares, $0.001 par value (200,000,000 shares authorized, 9,710,243 and 9,857,301 shares issued and outstanding as of March 31, 2025 and December 31, 2024 respectively)		9,711	9,858
Additional paid-in capital		243,003,489	246,622,366
Accumulated undistributed (overdistributed) earnings		(4,654,383)	(5,802,119)
Total net assets		$ 238,358,817	$ 240,830,105
Net asset value per share (in dollars per share)		$ 24.55	$ 24.43
Non-controlled/Non-affiliated Investments [Member]
Investments at fair value:
Investments at fair value		$ 324,202,946	$ 326,959,520
Controlled/Affiliate Investments [Member]
Investments at fair value:
Investments at fair value		$ 51,620,616	$ 50,680,798

[1] Because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Company’s board of directors (the “Board”) as required by the 1940 Act. See Note 4 “Fair Value Measurements” in the accompanying notes to the consolidated financial statements.